Showing results (131-140 of 214) with videos related to
Sort By:
Pageof 22
Scientific Reports|November 6, 2015
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal TransitionAsfar S Azmi, Irfana Muqbil, Jack Wu, et al.Frontiers in Oncology|November 11, 2021
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon CancerAmr Mohamed, Renjian Jiang, Philip A Philip, et al.Annals of Surgical Oncology|August 6, 2003
Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcomeLisa A Newman, Nat L Pernick, Volkan Adsay, et al.Advances in Radiation Oncology|December 8, 2022
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation TherapyHusain Yar Khan, Mandana Kamgar, Amro Aboukameel, et al.Cancer|February 11, 2025
Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505Sameer H Patel, Sarah Colby, Davendra Sohal, et al.Journal of Ovarian Research|November 15, 2024
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumorsMary P Udumula, Faraz Rashid, Harshit Singh, et al.Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.American Journal of Clinical Oncology|September 1, 2007
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancerSameer P Desai, Basil F El-Rayes, Edgar Ben-Josef, et al.Journal of Pancreatic Cancer|September 28, 2019
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic CancerVaibhav Sahai, M Wasif Saif, Aparna Kalyan, et al.American Journal of Clinical Oncology|December 10, 2003
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II studySana Al-Sukhun, Mark M Zalupski, Edgar Ben-Josef, et al.Pageof 22